|Articles|July 1, 2003

ISTA begins phase III study of bromfenac

ISTA Pharmaceuticals Inc. has filed an investigational new drug application with the FDA to begin a phase III study of bromfenac.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME